| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Budesonide Impurity 33(Triethylamine Salt) |
布地奈德雜質(zhì)33 |
1436872-65-9 |
詳細(xì)
|
| Eperisone Impurity E |
乙哌立松雜質(zhì) E |
|
詳細(xì)
|
| Edoxaban Impurity 45(Hydrochloride) |
依度沙班雜質(zhì)45(鹽酸鹽) |
|
詳細(xì)
|
| Candesartan Cilexetil EP Impurity G |
坎地沙坦 |
139481-59-7 |
詳細(xì)
|
| Mometasone Furoate EP Impurity G |
莫美他松 |
105102-22-5 |
詳細(xì)
|
| Posaconazole Impurity 89 |
泊沙康唑雜質(zhì)44 |
357189-97-0 |
詳細(xì)
|
| Oxacillin EP Impurity D |
苯唑西林鈉EP雜質(zhì)D |
1642559-63-4 |
詳細(xì)
|
| Urapidil Impurity 16 |
4-(3-羥丙基氨基)-1,3-二甲基脲嘧啶 |
34654-80-3 |
詳細(xì)
|
| Cilastatin EP Impurity E |
西司他丁EP雜質(zhì)E鹽酸鹽 |
1174657-07-8 |
詳細(xì)
|
| Sorafenib Impurity 50 |
5-氯-N-甲基吡啶甲基酰胺 |
1086110-81-7 |
詳細(xì)
|
| Olmesartan Medoxomil Impurity 74 |
厄貝沙坦雜質(zhì)14 |
133690-91-2 |
詳細(xì)
|
| Dapagliflozin Impurity 46 |
達格列凈雜質(zhì)46 |
|
詳細(xì)
|
| Landiolol Impurity 55 |
蘭地洛爾雜質(zhì)55 |
|
詳細(xì)
|
| Sorafenib Impurity 53 |
N-METHYL-4-(METHYLAMINO)PICOLINAMIDE |
1065074-98-7 |
詳細(xì)
|
| Nicergoline Impurity A |
尼麥角林雜質(zhì) A |
38536-28-6 |
詳細(xì)
|
| Olmesartan Medoxomil Impurity 73 |
纈沙坦雜質(zhì)34 |
152708-24-2 |
詳細(xì)
|
| Moxifloxacin Impurity 80 |
莫西沙星雜質(zhì)80 |
133492-64-5 |
詳細(xì)
|
| Nebivolol Impurity 14 |
奈比洛爾雜質(zhì) |
99199-91-4 |
詳細(xì)
|
| Sorafenib Impurity 49 |
索拉非尼雜質(zhì)49 |
1850693-67-2 |
詳細(xì)
|
| Ruxolitinib Impurity 4 |
蘆可替尼雜質(zhì)4 |
2606144-45-8 |
詳細(xì)
|
| Bumetanide Impurity 32 |
布美他尼雜質(zhì)32 |
|
詳細(xì)
|
| Vonoprazan Impurity 74 |
沃諾拉贊雜質(zhì)171 |
2932441-73-9 |
詳細(xì)
|
| Fosfomycin Enantiomer Impurity |
[[2S,3R,(+)]-3-Methyloxiran-2-yl]phosphonic acid |
26017-03-8 |
詳細(xì)
|
| Rizatriptan EP Impurity C |
利扎曲普坦雜質(zhì)C |
208941-96-2 |
詳細(xì)
|
| Ruxolitinib Impurity 11 |
1H-吡唑-1-丙腈,Β-環(huán)戊基-4-[7-(羥基甲基)-7H-吡咯并[2,3-D]嘧啶-4-基]-,(ΒR)- |
1236033-03-6 |
詳細(xì)
|
| Pitavastatin Impurity 54 |
去氟匹伐他汀鈣鹽雜質(zhì) |
1258947-30-6 |
詳細(xì)
|
| LCZ696(valsartan + sacubitril) impurity 56 |
LCZ 696雜質(zhì)C |
149709-63-7 |
詳細(xì)
|
| Tirofiban Impurity 18 |
3-氯替羅非班 |
2713130-63-1 |
詳細(xì)
|
| Oxacillin Impurity I |
苯唑西林鈉EP雜質(zhì)I |
|
詳細(xì)
|
| Dyclonine Impurity 2 |
達克羅寧雜質(zhì)2 |
66536-15-0 |
詳細(xì)
|
| Vonoprazan Impurity 69 |
Vonoprazan Impuirty 84 |
2358783-64-7 |
詳細(xì)
|
| Gadobutrol EP Impurity A (4 Hydrochloride) |
釓布醇EP雜質(zhì)A(4鹽酸鹽) |
2514736-59-3 |
詳細(xì)
|
| Moxifloxacin Impurity 78 |
4,5,6,7-四氯鄰苯二甲酰亞胺 |
1571-13-7 |
詳細(xì)
|
| Rocuronium Bromide Impurity 38 |
Rocuronium Bromide Impurity 38 |
|
詳細(xì)
|
| Dapagliflozin Impurity 45 |
Dapagliflozin Impurity 48 |
2069934-29-6 |
詳細(xì)
|
| Avatrombopag Impurity 35 |
阿伐曲泊帕雜質(zhì)35 |
|
詳細(xì)
|
| Indomethacin Sorbitol Ester |
吲哚美辛山梨醇酯 |
|
詳細(xì)
|
| Azilsartan Impurity U-4 |
阿齊沙坦雜質(zhì)U-4 |
|
詳細(xì)
|
| Landiolol Impurity 45 |
蘭地洛爾雜質(zhì)28 |
69630-20-2 |
詳細(xì)
|
| Carboprost Impurity 12 |
[3AS-(3AALPHA,4ALPHA,5BETA,6AALPHA)]-5-(苯甲酰氧基)六氫-4-(羥基甲基)-2H-環(huán)戊二烯并[B]呋喃-2-酮 |
53275-53-9 |
詳細(xì)
|
| rac-Phenylephrine EP Impurity D |
外消旋芐基去氧腎上腺素 |
1159977-09-9 |
詳細(xì)
|
| Salmeterol EP Impurity D |
沙美特羅雜質(zhì)D |
1391052-04-2 |
詳細(xì)
|
| Pemetrexed EP Impurity D |
培美曲塞雜質(zhì)D |
144051-68-3 |
詳細(xì)
|
| Ilaprazole Impurity 4 |
2-[(4-甲氧基-3-甲基-2-吡啶基)甲基]磺?；鵠-6-(1H-吡咯-1-基)-1H-苯并咪唑 |
172152-37-3 |
詳細(xì)
|
| Nimodipine Impurity 28 |
Nimodipine Metabolite 3 |
82219-48-5 |
詳細(xì)
|
| Revefenacin Impurity 12 |
雷芬那辛雜質(zhì)12 |
938143-02-3 |
詳細(xì)
|
| Baloxavir Enantiomer |
巴洛沙韋異構(gòu)體 |
2986084-03-9 |
詳細(xì)
|
| cis-Lacidipine |
順式拉西地平 |
103890-79-5 |
詳細(xì)
|
| Riociguat Impurity 30 |
2-[1-[(2-氟苯基基)甲基]-1H-吡唑并[3 |
428854-24-4 |
詳細(xì)
|
| Posaconazole Impurity 20 |
泊沙康唑中間體6 |
160709-02-4 |
詳細(xì)
|
| Nicardipine EP Impurity A(Hydrochloride) |
脫氫鹽酸尼卡地平 |
1216817-27-4 |
詳細(xì)
|
| Gadobutrol EP Impurity B |
rel-10-[(1R,2S)-2,3-Dihydroxy-1-(hydroxyMethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid |
151852-61-8 |
詳細(xì)
|
| Itraconazole Impurity 19 |
伊曲康唑雜質(zhì)19 |
1437468-62-6 |
詳細(xì)
|
| Amikacin Impurity L |
阿米卡星雜質(zhì) |
1793053-92-5 |
詳細(xì)
|
| Metoclopramide Impurity 14 |
甲氧氯普胺雜質(zhì)1 |
3761-48-6 |
詳細(xì)
|
| Apalutamide Impurity 11 |
阿帕魯胺雜質(zhì)-11 |
|
詳細(xì)
|
| Riociguat Impurity 28 |
|
|
詳細(xì)
|
| Peramivir Intermediate Impurity 35(Hydrochloride) |
帕拉米韋中間體雜質(zhì)35(鹽酸鹽) |
|
詳細(xì)
|
| Indomethacin Polyethylene Glycol Ester |
吲哚美辛聚乙二醇酯 |
|
詳細(xì)
|
| Glycine Deoxycholic Acid Ethyl Ester |
甘氨脫氧膽酸乙酯 |
70779-06-5 |
詳細(xì)
|
| Mosapride Impurity 8 |
莫沙必利雜質(zhì)8 |
|
詳細(xì)
|
| Dolutegravir Impurity 7 |
多替拉韋雜質(zhì)4 |
1863916-88-4 |
詳細(xì)
|
| Rizatriptan EP Impurity B |
Rizatriptan EP Impurity B |
|
詳細(xì)
|
| Ilaprazole Impurity 9 |
Ilaprazole Impurity 5 (Ilaprazole Pyridine N-Oxide) |
2285346-44-1 |
詳細(xì)
|
| Ruxolitinib Impurity 25 |
蘆可替尼雜質(zhì)5 |
1911644-32-0 |
詳細(xì)
|
| Azilsartan Impurity U-7 |
阿齊沙坦雜質(zhì)U-7 |
|
詳細(xì)
|
| Thiazolylacetylglycine Oxime Acetal |
THIAZOLYLACETYLGLYCINE OXIME ACETAL |
178422-40-7 |
詳細(xì)
|
| Amikacin EP Impurity H |
AMikacin B |
48237-20-3 |
詳細(xì)
|
| Landiolol impurity 16 |
4-MorpholinecarboxaMide, N-(2-aMinoethyl)- |
69630-16-6 |
詳細(xì)
|
| Dipyridamole EP Impurity E |
DipyridaMole EP IMpurity E |
2365420-11-5 |
詳細(xì)
|
| Mometasone Furoate EP Impurity H |
21-羥基 去氯糠酸莫米松(雜質(zhì)) |
148596-90-1 |
詳細(xì)
|
| Isavuconazole Impurity 29 |
艾沙康唑雜質(zhì)29 |
|
詳細(xì)
|
| Mirogabalin Impurity 4 |
米羅巴林DB01 |
1235479-61-4 |
詳細(xì)
|
| Edoxaban Impurity 28 |
N,N-雙-(5-氯-吡啶-2-基)-草酰胺 |
349125-14-0 |
詳細(xì)
|
| Oxacillin EP Impurity B |
(4S)-4-Carboxy-5,5-dimethyl-α-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-2-thiazolidineacetic acid |
1642629-95-5 |
詳細(xì)
|
| Metoclopramide Impurity 22 |
甲氧氯普胺雜質(zhì)31 |
476614-80-9 |
詳細(xì)
|
| Olodaterol Impurity 18 |
|
2727170-18-3 |
詳細(xì)
|
| Doxofylline Impurity 27 |
二羥丙茶堿雜質(zhì)2 |
93284-16-3 |
詳細(xì)
|
| Metoclopramide EP Impurity G |
甲氧氯普安N氧化物 |
171367-22-9 |
詳細(xì)
|
| Nimodipine EP Impurity B |
1,4-二氫-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二甲酸二異丙酯 |
21881-78-7 |
詳細(xì)
|
| Raltitrexed Impurity 1 |
雷替曲塞雜質(zhì)1 |
1378372-01-0 |
詳細(xì)
|
| Irbesartan Impurity 23 |
(2-(1H-四唑-5-基)-[1,1-二聯(lián)苯]-4-基)甲胺 |
147225-68-1 |
詳細(xì)
|
| Eperisone Impurity 13 |
間乙基苯丙酮 |
191543-16-5 |
詳細(xì)
|
| Nebivolol Impurity 47 |
奈必洛爾雜質(zhì)47 |
1030385-16-0 |
詳細(xì)
|
| Tirofiban Impurity 21 |
鹽酸替羅非班雜質(zhì)7 |
2250244-28-9 |
詳細(xì)
|
| Morinidazole Impurity 10 |
奧硝唑雜質(zhì)7 |
1348117-98-5 |
詳細(xì)
|
| (S,R)-Camphorsulfonic acid Ethyl Ester |
((1S,4R)-7,7-二甲基-2-氧代雙環(huán)[2.2.1]庚-1-基)甲磺酸乙酯 |
154335-57-6 |
詳細(xì)
|
| Baloxavir Impurity 25 |
巴洛沙韋酯雜質(zhì)35 |
2136287-69-7 |
詳細(xì)
|
| Sorafenib Impurity 54 |
4-氯-吡啶-2-酰氯 |
53750-66-6 |
詳細(xì)
|
| Nicergoline Impurity B |
1-去甲基尼麥角林 |
35264-46-1 |
詳細(xì)
|
| Baricitinib Impurity 27 |
巴瑞克替尼雜質(zhì)06 |
2402776-83-2 |
詳細(xì)
|
| Indobufen Impurity 42 |
吲哚布芬雜質(zhì) 42 |
|
詳細(xì)
|
| Mirogabalin Impurity 5 |
米洛巴林雜質(zhì)03 |
2166206-19-3 |
詳細(xì)
|
| Montelukast EP Impurity C |
孟魯斯特亞砜 |
909849-96-3 |
詳細(xì)
|
| Nifedipine Impurity 1 |
貝尼地平雜質(zhì)B |
21829-09-4 |
詳細(xì)
|
| (S,R)-Camphorsulfonic acid Methyl Ester |
(1S)-(+)-10-樟腦磺酸甲酯 |
62319-13-5 |
詳細(xì)
|
| Sorafenib Impurity 52 |
N-甲基-3,6-二氯吡啶甲酰胺 |
1021077-12-2 |
詳細(xì)
|
| Dolutegravir Impurity 8 |
度魯特韋雜質(zhì) |
1863916-87-3 |
詳細(xì)
|
| Colchicine EP Impurity D |
秋水仙堿苷 |
477-29-2 |
詳細(xì)
|
| Verapamil EP Impurity I |
維拉帕米EP雜質(zhì)I |
2893-91-6 |
詳細(xì)
|